Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

Abroad (travel likely)RecruitingPHASE1

Conditions

Herpes Zoster (HZ)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Guangdong Provincial Center for Disease Control and Prevention, Meizhou, China
Contact: Study coordinator (Weihua Huang) · 2051274292@qq.com · 8613690896555

Study leads

Renfeng Fan
Principal Investigator
Guangdong Center for Disease Prevention and Control

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Reduced Vaccine Response to HZ/su in SLE

Vaccine Reaction · Zoster · Systemic Lupus Erythematosus

Abroad (travel likely)Recruiting

Seoul, South Korea

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant

Herpes Zoster

Abroad (travel likely)RecruitingPHASE1, PHASE2

Brussels, Belgium · Ghent, Belgium

A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Herpes Zoster (HZ)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Wuhan, China

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Herpes Zoster (HZ) · Vascular Dementia

Abroad (travel likely)Recruiting

Houston, United States · Webster, United States